Phase 2 study of TRPH-222
Latest Information Update: 24 Feb 2022
At a glance
- Drugs TRPH 222 (Primary)
- Indications B-cell lymphoma
- Focus Therapeutic Use
- 24 Feb 2022 New trial record
- 22 Feb 2022 According to a Triphase Accelerator Corporation media release, the company is preparing for upcoming conversations with regulatory agencies on a Phase 2 study plan.